Prostatype Genomics AB (OSTO:PROGEN) Change In Inventory : kr-0.14 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Change In Inventory?

Prostatype Genomics AB's change in inventory for the quarter that ended in Jun. 2023 was kr0.00 Mil. It means Prostatype Genomics AB's inventory declined by kr0.00 Mil from Mar. 2023 to Jun. 2023 .

Prostatype Genomics AB's change in inventory for the fiscal year that ended in Dec. 2023 was kr-0.02 Mil. It means Prostatype Genomics AB's inventory increased by kr0.02 Mil from Dec. 2022 to Dec. 2023 .

Prostatype Genomics AB's Total Inventories for the quarter that ended in Jun. 2023 was kr0.16 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Prostatype Genomics AB's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Prostatype Genomics AB's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 2.79.

Prostatype Genomics AB Change In Inventory Historical Data

The historical data trend for Prostatype Genomics AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Change In Inventory Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Change In Inventory

-0.25

-0.07

0.21

-0.02

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial											-0.20	0.16	-0.11	-	-

Prostatype Genomics AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.14 Mil.

Prostatype Genomics AB (OSTO:PROGEN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Prostatype Genomics AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.1565	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Prostatype Genomics AB's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0.1565
	=	0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Prostatype Genomics AB's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.1565	/	0.056
	=	2.79

Prostatype Genomics AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB (OSTO:PROGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

PGO:Germany

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines